Anti-IL-23p19 antibody treatment in an imiquimod-induced psoriasis mouse model increased the number of Foxp3+ cells in the lesions, and adoptive transfer of Tregs from anti-IL-23p19 antibody-treated mice improved psoriasis-like dermatitis in the donor mice [49]. This evidence concerns the gene IL23A and psoriasis.